ID: ALA4638787

Max Phase: Preclinical

Molecular Formula: C29H25N5O3

Molecular Weight: 491.55

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cn1c(-c2c[nH]c3cc(C#N)ccc23)nc2cc(C(=O)N3CCOC(c4ccccc4)C3CO)ccc21

Standard InChI:  InChI=1S/C29H25N5O3/c1-33-25-10-8-20(29(36)34-11-12-37-27(26(34)17-35)19-5-3-2-4-6-19)14-24(25)32-28(33)22-16-31-23-13-18(15-30)7-9-21(22)23/h2-10,13-14,16,26-27,31,35H,11-12,17H2,1H3

Standard InChI Key:  AWMXHLQMVPWYKV-UHFFFAOYSA-N

Associated Targets(Human)

Neurokinin 3 receptor 1696 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neurokinin 1 receptor 6273 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neurokinin 2 receptor 3341 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 491.55Molecular Weight (Monoisotopic): 491.1957AlogP: 4.17#Rotatable Bonds: 4
Polar Surface Area: 107.17Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.76CX Basic pKa: 3.71CX LogP: 3.70CX LogD: 3.70
Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.39Np Likeness Score: -0.75

References

1. Song M, Hwang GT..  (2020)  DNA-Encoded Library Screening as Core Platform Technology in Drug Discovery: Its Synthetic Method Development and Applications in DEL Synthesis.,  63  (13): [PMID:32039601] [10.1021/acs.jmedchem.9b01782]

Source